Cargando…
Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse
The plasmacytoid dendritic cells (pDCs) express a high level of Toll-like receptor 9 (TLR-9), which recognizes viral DNA. Activated via TLR-9, pDCs also secrete large amounts of type I interferon which are involved either in stimulation or down regulation of immune response in multiple sclerosis (MS...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022734/ https://www.ncbi.nlm.nih.gov/pubmed/21214939 http://dx.doi.org/10.1186/1742-2094-8-2 |
_version_ | 1782196565777055744 |
---|---|
author | Longhini, Ana Leda F von Glehn, Felipe Brandão, Carlos Otávio de Paula, Rosemeire FO Pradella, Fernando Moraes, Adriel S Farias, Alessandro S Oliveira, Elaine C Quispe-Cabanillas, Juan G Abreu, Cassiana Horta Damasceno, Alfredo Damasceno, Benito P Balashov, Konstantin E Santos, Leonilda MB |
author_facet | Longhini, Ana Leda F von Glehn, Felipe Brandão, Carlos Otávio de Paula, Rosemeire FO Pradella, Fernando Moraes, Adriel S Farias, Alessandro S Oliveira, Elaine C Quispe-Cabanillas, Juan G Abreu, Cassiana Horta Damasceno, Alfredo Damasceno, Benito P Balashov, Konstantin E Santos, Leonilda MB |
author_sort | Longhini, Ana Leda F |
collection | PubMed |
description | The plasmacytoid dendritic cells (pDCs) express a high level of Toll-like receptor 9 (TLR-9), which recognizes viral DNA. Activated via TLR-9, pDCs also secrete large amounts of type I interferon which are involved either in stimulation or down regulation of immune response in multiple sclerosis (MS). In the present study, we determinate pDCs levels by flow cytometry in Cerebrospinal Fluid (CSF) and Peripheral Blood from MS patients in relapsing and in remitting phases of the disease, comparing with other non-inflammatory diseases (OND). We provide evidence that MS patients in relapse without any treatment have a significantly (p < 0.01) higher percentage of pDCs in CSF than do patients in remission or those with OND. No change in the percentage of pDCs was observed in the peripheral blood of any of these patients. The increase of pDCs in central nervous system during relapse may be explained either by a virus infection or a down regulatory process. |
format | Text |
id | pubmed-3022734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30227342011-01-19 Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse Longhini, Ana Leda F von Glehn, Felipe Brandão, Carlos Otávio de Paula, Rosemeire FO Pradella, Fernando Moraes, Adriel S Farias, Alessandro S Oliveira, Elaine C Quispe-Cabanillas, Juan G Abreu, Cassiana Horta Damasceno, Alfredo Damasceno, Benito P Balashov, Konstantin E Santos, Leonilda MB J Neuroinflammation Short Report The plasmacytoid dendritic cells (pDCs) express a high level of Toll-like receptor 9 (TLR-9), which recognizes viral DNA. Activated via TLR-9, pDCs also secrete large amounts of type I interferon which are involved either in stimulation or down regulation of immune response in multiple sclerosis (MS). In the present study, we determinate pDCs levels by flow cytometry in Cerebrospinal Fluid (CSF) and Peripheral Blood from MS patients in relapsing and in remitting phases of the disease, comparing with other non-inflammatory diseases (OND). We provide evidence that MS patients in relapse without any treatment have a significantly (p < 0.01) higher percentage of pDCs in CSF than do patients in remission or those with OND. No change in the percentage of pDCs was observed in the peripheral blood of any of these patients. The increase of pDCs in central nervous system during relapse may be explained either by a virus infection or a down regulatory process. BioMed Central 2011-01-07 /pmc/articles/PMC3022734/ /pubmed/21214939 http://dx.doi.org/10.1186/1742-2094-8-2 Text en Copyright ©2011 Longhini et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Longhini, Ana Leda F von Glehn, Felipe Brandão, Carlos Otávio de Paula, Rosemeire FO Pradella, Fernando Moraes, Adriel S Farias, Alessandro S Oliveira, Elaine C Quispe-Cabanillas, Juan G Abreu, Cassiana Horta Damasceno, Alfredo Damasceno, Benito P Balashov, Konstantin E Santos, Leonilda MB Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse |
title | Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse |
title_full | Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse |
title_fullStr | Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse |
title_full_unstemmed | Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse |
title_short | Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse |
title_sort | plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022734/ https://www.ncbi.nlm.nih.gov/pubmed/21214939 http://dx.doi.org/10.1186/1742-2094-8-2 |
work_keys_str_mv | AT longhinianaledaf plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT vonglehnfelipe plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT brandaocarlosotavio plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT depaularosemeirefo plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT pradellafernando plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT moraesadriels plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT fariasalessandros plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT oliveiraelainec plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT quispecabanillasjuang plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT abreucassianahorta plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT damascenoalfredo plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT damascenobenitop plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT balashovkonstantine plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse AT santosleonildamb plasmacytoiddendriticcellsareincreasedincerebrospinalfluidofuntreatedpatientsduringmultiplesclerosisrelapse |